Karl Kovacs
Bedminster, NJ ***** **********@*******.***
GLOBAL CGxP QUALITY MANAGEMENT SYSTEMS LEAD
Leverages Quality Management Systems to drive operational excellence
Proven success in enhancing quality systems, ensuring compliance, and
fostering continuous improvement across global supply chains
EXPERIENCE
Crowne Pharmaceutical Consulting Services
Governance, oversight and support of OTC, pharmaceutical, diagnostic and combination products
CGxP Quality Management Systems Lead 2008 – current
(Documentation, Training, Event Management, Investigation, CAPA & Change Management Systems)
HISTORY OF CONTRIBUTION INCLUDES
Quality Leadership
As MBA student: Learned the challenges and opportunities of Learning Organizations and Reliability Organizations
As Site Quality Lead: Communicated by example that Quality and management were each employee’s responsibility
Result: Increased ratio of Preventive Actions (PA) to Corrective Actions (CA) Created an employee Suggestion Program
Motivated and inspired Site personnel to develop a Best-First-Time Quality Culture
Result: Decreased batch documentation review period by ~50%
Result: Decreased in-process and finished goods’ reject rates to ~0%
Result: Enabled a Learning Organization’s Continuous Improvement culture
Result: Embedded a Reliability Organization’s Continual Improvement culture
Result: Operations and culture transformed from reactive mode (CA) to proactive mode (PA)
As process area leader: Developed an already-good Department into a company-recognized Center of Excellence
Led Lean Six Sigma process re-engineering of CMO’s supply chain
Enhanced the CMO’s systems, staffing and skilling to ensure full-cycle, supply-chain productivity
As project manager: Collaborated with global partners to create a harmonized, aligned Quality Management System
Negotiated Quality trade-off decisions across the global supply-chain network
Result: Fulfilled commitments to FDA and HC to align and harmonize company’s Quality Systems
Quality Compliance
As consultant: Evaluated CMO and its suppliers’ Quality compliance with
previous Agreements and current Regulatory requirements and commitments
Collaborated with Line Managers, SMEs and CMO stakeholders
Result: Established employee curricula
Authored Documentation and Training Quality Management Systems
Communicated Quality duties by training, coaching and mentoring client’s personnel
As project manager: Ensured the supply chain’s data-based Quality performance, reliability and integrity
Collaborated with CMO matrix teams to develop, implement and support Key Performance Metrics
Karl Kovacs page 2/3
Knowledge Barrier: overcome by complete, compliant, accurate Documentation and Training Systems
As MBA student: Learned the necessity of effective, efficient baton passing of information at each Moment of Truth
As process area leader: Led product, process and equipment transfers for transferring and receiving organizations
(Site-to-Site transfers and Bench-to-Commercial scale ups)
Participated in the negotiation and oversight of Business and Quality Agreements
As project manager: Led a 15-person matrix team during supply-chain, value-stream analyses
Presented capability supply-chain assessments and productivity recommendations to management
Result: Minimized potential gaps, duplications, delays, frictions, erosions, decays and destructions
at each information-handoff
Result: Company culture began to transition from adversarial to collegial
Knowledge Management: enabled by Site Readiness (Inspection and Audit Systems)
As auditor: Performed internal and CMO compliance audits (FDA Six-System Inspection Model)
Prepared and defended audit reports
Collaborated to improve adherence to both Quality Agreements and Regulatory Guidelines
As Site Quality Lead: Prepared 6 direct and 40 indirect reports for customer audits and Regulatory inspections
Hosted FDA, EMA and HC inspections
Result: Avoided significant Regulatory Observations and actions
As Plant Manager: Prepared 10 direct and 80 indirect reports for Pre-Approval Inspection (“PAI”)
Stabilized, remediated and improved Observed Quality issues
Result: FDA approved company’s NDA
As Operations resource: Front-room roles during Regulatory inspections
Result: Avoided significant Regulatory observations and actions
Customer-facing roles during audits (e.g. primary Quality and technical contact)
Result: Obtained contracts and Preferred Vendor status
Result: Created profitable, productive relationships
Result: Established mutual goals with customers and product and service providers
Knowledge Management: powered by Site Response (Deviation and Complaint Investigation Systems)
As consultant: Authored Event Management Quality System to ensure accurate and timely reporting of each observation
Included Complaint intake dialog, confidential recording of complainant information, triaging according to assessd severity, response and resolution notification
Result: FDA Inspector determined the System to be “Acceptable”
Initiated then led Lean Six Sigma process re-engineering of Investigation process
Authored Investigation Quality Management System to ensure robust search for Root Cause
Result: Improved the Investigation “closed within 25 day” metric from 15% to 70% in 6 months
Prepared responses to Health Authority 483 letters, Consent Decree-negotiated commitments
As Site Quality Lead: Single point of contact for FDA notifications:
Field Alerts, product recalls, retrievals, reconciliations and destructions
Created Top Gun Investigator program, then trained, coached and mentored those Investigators Result: Rigidity of Evaluation-Flexibility of Response Method enabled robust investigations
Developed cultural framework to effectively, efficiently identify Root Causes
Result: Created a Root Cause Analysis Form to enable more-accurate metrics and trend analyses
Karl Kovacs page 3/3
Risk Management: aligned with Organizational Change (CAPA and Change Control Quality Systems)
As consultant: Led CMO matrix team to establish risk recognition/ risk mitigation/ risk quantitation systems
Authored CAPA Quality Management System to ensure compliance incidents were effectively addressed
Leveraged Risk Management principles to facilitate Strategic, Operational and Tactical decision-making
Result: FDA Inspector determined the system and the company’s adherence to it to be “Acceptable”
Result: Enhanced and standardized output, communications and terminology
(including Effectiveness Checks)
Result: Assessed/ ensured Investigation method compliance and effectiveness
Timely Root Cause analyses, identification, response
Accurate CAPA proposal adequacy/ compliance
CAPA closure timeliness and effectiveness
Result: Enabled/ facilitated Continuous Improvement and development of cultural shared purposes
Collaborated to create a Change Control System that closed information loops
Recognized direct and indirect resistance to proposed organizational change and addressed each cause
Aligned the System with national and regional Regulatory Guidances
Harmonized the System across the company’s operating sites
Result: Company demonstrated effectiveness of implemented System to both customers and regulators
Result: Company maintained uninterrupted global supply chain processes
(from API suppliers to Third Parties, distributors and patients)
Result: Company fulfilled Consent Decree commitments on time (i.e. without incurring penalties)
Led supply-chain, value-stream, cross-functional team exercises
Result: Helped identify vulnerability of organization’s critical assets to specific threats (AS-IS)
Result: Facilitated decisions whether to avoid, mitigate, accept or offload risk and risk’s effects
Result: Defined and designed new processes with embedded risk control/ containment (TO-BE)
Objective: goal line
Scope: side lines
Rationale: competitive advantage
Evaluation: tools and methods
Controls: governance, oversight and timing
EDUCATION
Master of Business Administration Texas A&M University, TX
Focus Organizational Change Leadership
Risk Management
Operational Excellence
Project Management
GPA 3.9 ( Phi Kappa Phi Honor Society )